Full text
PDF

Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alter M. J. Epidemiology of hepatitis C in the West. Semin Liver Dis. 1995 Feb;15(1):5–14. doi: 10.1055/s-2007-1007259. [DOI] [PubMed] [Google Scholar]
- Booth J. C., Brown J. L., Thomas H. C. The management of chronic hepatitis C virus infection. Gut. 1995 Oct;37(4):449–454. doi: 10.1136/gut.37.4.449. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Di Bisceglie A. M., Goodman Z. D., Ishak K. G., Hoofnagle J. H., Melpolder J. J., Alter H. J. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology. 1991 Dec;14(6):969–974. doi: 10.1016/0270-9139(91)90113-a. [DOI] [PubMed] [Google Scholar]
- Donahue J. G., Muñoz A., Ness P. M., Brown D. E., Jr, Yawn D. H., McAllister H. A., Jr, Reitz B. A., Nelson K. E. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med. 1992 Aug 6;327(6):369–373. doi: 10.1056/NEJM199208063270601. [DOI] [PubMed] [Google Scholar]
- Dusheiko G. M. Rolling review--the pathogenesis, diagnosis and management of viral hepatitis. Aliment Pharmacol Ther. 1994 Apr;8(2):229–253. doi: 10.1111/j.1365-2036.1994.tb00283.x. [DOI] [PubMed] [Google Scholar]
- Gordon S. C., Elloway R. S., Long J. C., Dmuchowski C. F. The pathology of hepatitis C as a function of mode of transmission: blood transfusion vs. intravenous drug use. Hepatology. 1993 Dec;18(6):1338–1343. [PubMed] [Google Scholar]
- McMahon R. F., Yates A. J., McLindon J., Babbs C., Love E. M., Warnes T. W. The histopathological features of asymptomatic hepatitis C virus-antibody positive blood donors. Histopathology. 1994 Jun;24(6):517–524. doi: 10.1111/j.1365-2559.1994.tb00018.x. [DOI] [PubMed] [Google Scholar]
- Neugut A. I., Pita S. Role of sigmoidoscopy in screening for colorectal cancer: a critical review. Gastroenterology. 1988 Aug;95(2):492–499. doi: 10.1016/0016-5085(88)90511-2. [DOI] [PubMed] [Google Scholar]
- Poynard T., Bedossa P., Chevallier M., Mathurin P., Lemonnier C., Trepo C., Couzigou P., Payen J. L., Sajus M., Costa J. M. A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group. N Engl J Med. 1995 Jun 1;332(22):1457–1462. doi: 10.1056/NEJM199506013322201. [DOI] [PubMed] [Google Scholar]
- Seeff L. B., Buskell-Bales Z., Wright E. C., Durako S. J., Alter H. J., Iber F. L., Hollinger F. B., Gitnick G., Knodell R. G., Perrillo R. P. Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group. N Engl J Med. 1992 Dec 31;327(27):1906–1911. doi: 10.1056/NEJM199212313272703. [DOI] [PubMed] [Google Scholar]
- Shiell A., Briggs A., Farrell G. C. The cost effectiveness of alpha interferon in the treatment of chronic active hepatitis C. Med J Aust. 1994 Mar 7;160(5):268–272. [PubMed] [Google Scholar]
- Thomas D. L., Zenilman J. M., Alter H. J., Shih J. W., Galai N., Carella A. V., Quinn T. C. Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore--an analysis of 309 sex partnerships. J Infect Dis. 1995 Apr;171(4):768–775. doi: 10.1093/infdis/171.4.768. [DOI] [PubMed] [Google Scholar]
- Tremolada F., Casarin C., Alberti A., Drago C., Tagger A., Ribero M. L., Realdi G. Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis. J Hepatol. 1992 Nov;16(3):273–281. doi: 10.1016/s0168-8278(05)80657-9. [DOI] [PubMed] [Google Scholar]
- Zanetti A. R., Tanzi E., Paccagnini S., Principi N., Pizzocolo G., Caccamo M. L., D'Amico E., Cambiè G., Vecchi L. Mother-to-infant transmission of hepatitis C virus. Lombardy Study Group on Vertical HCV Transmission. Lancet. 1995 Feb 4;345(8945):289–291. doi: 10.1016/s0140-6736(95)90277-5. [DOI] [PubMed] [Google Scholar]
